
AAD 2026: Almirall Showcases New Clinical and Real-World Data on Atopic Dermatitis, Psoriasis, Actinic Keratosis, and Acne
AAD 2026: Almirall Presents New Clinical and Real‑world Evidence Across Atopic Dermatitis, Psoriasis, Actinic Keratosis and Acne Almirall S.A. a global biopharmaceutical company dedicated to medical dermatology, is presenting a broad range of clinical and real‑world data across its portfolio…












